Multidrug-Resistant Typhoid in Children: Presentation and Clinical Features

Abstract

Typhoid accounts for 8% of pediatric admissions to the Aga Khan University Hospital in Karachi, Pakistan. Over a 4-year period (1986–1989), 355 children had typhoid documented by culture of blood or bone marrow. Strains of Salmonella, resistant to ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole accounted for 20% of these cases. Compared with children infected by drug-susceptible strains of Salmonella, children with multiresistant infection were generally sicker at presentation and were more likely to be assessed as appearing “toxic” (P < .001), as having disseminated intravascular coagulation (P < .01), and as exhibiting hepatomegaly (P < .01). The mortality was 4.2 % among children with multiresistant infection and 1.4% among those infected with strains susceptible to ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole; the higher mortality in the former group was probably due to a longer duration of illness (P < .05) and to ineffectual oral antimicrobial therapy before hospitalization.